LALPATHLAB
Dr. Lal Path Labs Ltd
Healthcare
Share price
₹2,006
Market cap
₹33,680 Cr
1Y return
▲ 30%
A leading diagnostic services provider in India, Dr. Lal PathLabs operates an integrated nationwide network delivering laboratory tests and comprehensive healthcare services. The company serves individual patients, hospitals, healthcare providers, and corporate clients through core diagnostic testing, disease diagnosis, prevention, monitoring, and treatment support. Its distinctive strength lies in combining consumer accessibility with a broad range of diagnostic capabilities and related health services across the country.
Investors holding Dr. Lal Path Labs Ltd
3.91%
2.49%
1.49%
1.47%
1.39%
1.15%
Recent moves 15
Moves15
1newest move
Members onlySBI Mutual FundIncreased
SBI Mutual Fund increased its stake in Dr. Lal Path Labs Ltd from 1.39% to 1.49% by acquiring 1,79,446 shares. The fund house now holds 25,04,029 shares of the diagnostic services company.
Read more
Nippon India Mutual FundDecreased
Nippon India Mutual Fund trimmed its stake in Dr. Lal Path Labs Ltd from 2.63% to 2.19%, selling 7,47,374 shares.
Read more
UTI Mutual FundDecreased
UTI Mutual Fund trimmed its stake in Dr. Lal PathLabs from 2.64% to 2.49%, selling 2,45,010 shares during the quarter. The fund now holds 41,85,354 shares of the healthcare company.
Read more
American Funds (Capital Group)Increased
American Funds (Capital Group) raised its stake in Dr. Lal Path Labs Ltd from 1.98% to 2.60%, buying 10,50,127 shares.
Read more
Aditya Birla Sun Life Mutual FundIncreased
Aditya Birla Sun Life Mutual Fund raised its stake in Dr. Lal Path Labs Ltd from 1.78% to 2.19% by acquiring 7,02,765 shares.
Read more
Tata Mutual FundDecreased
Tata Mutual Fund trimmed its stake in Dr. Lal PathLabs from 1.41% to 1.39%, selling 26,864 shares.
Read more
Tata Mutual FundDecreased
Tata Mutual Fund sold 5,66,848 shares of Dr. Lal Path Labs Ltd, reducing its stake from 1.75% to 1.41%.
Read more
SBI Mutual FundDecreased
SBI Mutual Fund decreased its stake in Dr. Lal Path Labs Ltd from 1.65% to 1.39%, selling 4,39,363 shares.
Read more
Invesco LtdDecreased
Invesco Ltd decreased its stake in Dr. Lal Path Labs Ltd from 2.28% to 1.37%, selling 1,533,350 shares.
Read more
American Funds (Capital Group)Increased
American Funds (Capital Group) increased its stake in Dr. Lal Path Labs Ltd from 1.42% to 1.98%, buying 946,108 shares.
Read more
Track the whales in Dr. Lal Path Labs Ltd
Get alerted the moment a top investor buys or sells.
Start 7 days for ₹1